In an initial small study, the use of inhaled corticosteroids at a dose of 1,000 μg of fluticasone per day was shown to be effective in reducing serum CRP levels in patients with COPD [36]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.